Empadus M (12.5mg/500mg) Tablet 1 Strip

Empadus M is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus when dual therapy with empagliflozin and metformin is appropriate. It is also indicated for reducing the risk of cardiovascular death in adults with type 2 diabetes and established cardiovascular disease.

This fixed-dose combination contains:

• Empagliflozin, a selective SGLT2 inhibitor that reduces renal glucose reabsorption and increases urinary glucose excretion.
• Metformin, a biguanide that reduces hepatic glucose production and enhances peripheral insulin sensitivity.

Together, they synergistically lower blood glucose levels and improve insulin action.

If a dose is missed, take it as soon as remembered. If it’s close to the next dose, skip the missed dose. Do not double the dose.

Caution is advised in:

• Elderly patients
• Patients at risk of dehydration
• History of genital infections
• Those undergoing surgery or radiologic procedures involving iodinated contrast agents
• Renal and hepatic function should be assessed before and during treatment